BD PharmingenTM Purified Rat Anti-Mouse CD44

Description

Blocking of hyaluronate binding by KM114 antibody. The BALB/c B-cell hybridoma BM-2 was incubated with fluorescein-conjugated hyaluronic acid FHA in the absence filled histogram or presence open histogram of purified antimouse CD44 antibody KM114 Cat. no. 558739, at 6 ig/ml . The grey line is the profile of cells without F-HA. Flow cytometry was performed on a BD FACScan Flow Cytometry System. Blocking of hyaluronate binding by KM114 antibody. The BALB/c B-cell hybridoma BM-2 was incubated with fluorescein-conjugated hyaluronic acid FHA in the absence filled histogram or presence open histogram of purified antimouse CD44 antibody KM114 Cat. no. 558739, at 6 ig/ml . The grey line is the profile of cells without F-HA. Flow cytometry was performed on a BD FACScan Flow Cytometry System. Show More Blocking of hyaluronate binding by KM114 antibody. The BALB/c B-cell hybridoma BM-2 was incubated with fluorescein-conjugated hyaluronic acid FHA in the absence filled histogram or presence open histogram of purified antimouse CD44 antibody KM114 Cat. no. 558739, at 6 ig/ml . The grey line is the profile of cells without F-HA. Flow cytometry was performed on a BD FACScan Flow Cytometry System.